Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Type: 2018 VS 2024 VS 2034
1.2.2 Lactulose
1.2.3 Rifaximin
1.2.4 Neomycin
1.2.5 Probiotics
1.2.6 Thiamine
1.3 Market by Application
1.3.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Growth by Application: 2018 VS 2024 VS 2034
1.3.2 Acute Liver Failure
1.3.3 Liver Cirrhosis
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Perspective (2018-2034)
2.2 Hepatic Encephalopathy (HE) Therapeutics Growth Trends by Region
2.2.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Region: 2018 VS 2024 VS 2034
2.2.2 Hepatic Encephalopathy (HE) Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Region (2024-2034)
2.3 Hepatic Encephalopathy (HE) Therapeutics Market Dynamics
2.3.1 Hepatic Encephalopathy (HE) Therapeutics Industry Trends
2.3.2 Hepatic Encephalopathy (HE) Therapeutics Market Drivers
2.3.3 Hepatic Encephalopathy (HE) Therapeutics Market Challenges
2.3.4 Hepatic Encephalopathy (HE) Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Revenue
3.1.1 Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hepatic Encephalopathy (HE) Therapeutics Revenue
3.4 Global Hepatic Encephalopathy (HE) Therapeutics Market Concentration Ratio
3.4.1 Global Hepatic Encephalopathy (HE) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hepatic Encephalopathy (HE) Therapeutics Revenue in 2024
3.5 Hepatic Encephalopathy (HE) Therapeutics Key Players Head office and Area Served
3.6 Key Players Hepatic Encephalopathy (HE) Therapeutics Product Solution and Service
3.7 Date of Enter into Hepatic Encephalopathy (HE) Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Type
4.1 Global Hepatic Encephalopathy (HE) Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Type (2024-2034)
5 Hepatic Encephalopathy (HE) Therapeutics Breakdown Data by Application
5.1 Global Hepatic Encephalopathy (HE) Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Hepatic Encephalopathy (HE) Therapeutics Market Size (2018-2034)
6.2 North America Hepatic Encephalopathy (HE) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
6.3 North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023)
6.4 North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hepatic Encephalopathy (HE) Therapeutics Market Size (2018-2034)
7.2 Europe Hepatic Encephalopathy (HE) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
7.3 Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023)
7.4 Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size (2018-2034)
8.2 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Growth Rate by Region: 2018 VS 2024 VS 2034
8.3 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2018-2023)
8.4 Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2024-2034)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size (2018-2034)
9.2 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
9.3 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023)
9.4 Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size (2018-2034)
10.2 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Growth Rate by Country: 2018 VS 2024 VS 2034
10.3 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023)
10.4 Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ASKA Pharmaceutical
11.1.1 ASKA Pharmaceutical Company Detail
11.1.2 ASKA Pharmaceutical Business Overview
11.1.3 ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Introduction
11.1.4 ASKA Pharmaceutical Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
11.1.5 ASKA Pharmaceutical Recent Development
11.2 COSMO PHARMACEUTICALS
11.2.1 COSMO PHARMACEUTICALS Company Detail
11.2.2 COSMO PHARMACEUTICALS Business Overview
11.2.3 COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Introduction
11.2.4 COSMO PHARMACEUTICALS Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
11.2.5 COSMO PHARMACEUTICALS Recent Development
11.3 Mallinckrodt
11.3.1 Mallinckrodt Company Detail
11.3.2 Mallinckrodt Business Overview
11.3.3 Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Introduction
11.3.4 Mallinckrodt Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
11.3.5 Mallinckrodt Recent Development
11.4 Valeant
11.4.1 Valeant Company Detail
11.4.2 Valeant Business Overview
11.4.3 Valeant Hepatic Encephalopathy (HE) Therapeutics Introduction
11.4.4 Valeant Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
11.4.5 Valeant Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2024 VS 2034
Table 2. Key Players of Lactulose
Table 3. Key Players of Rifaximin
Table 4. Key Players of Neomycin
Table 5. Key Players of Probiotics
Table 6. Key Players of Thiamine
Table 7. Global Hepatic Encephalopathy (HE) Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2024 VS 2034
Table 8. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 9. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 10. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Region (2018-2023)
Table 11. Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 12. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Region (2024-2034)
Table 13. Hepatic Encephalopathy (HE) Therapeutics Market Trends
Table 14. Hepatic Encephalopathy (HE) Therapeutics Market Drivers
Table 15. Hepatic Encephalopathy (HE) Therapeutics Market Challenges
Table 16. Hepatic Encephalopathy (HE) Therapeutics Market Restraints
Table 17. Global Hepatic Encephalopathy (HE) Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 18. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Players (2018-2023)
Table 19. Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy (HE) Therapeutics as of 2024)
Table 20. Ranking of Global Top Hepatic Encephalopathy (HE) Therapeutics Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Hepatic Encephalopathy (HE) Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hepatic Encephalopathy (HE) Therapeutics Product Solution and Service
Table 24. Date of Enter into Hepatic Encephalopathy (HE) Therapeutics Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 27. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type (2018-2023)
Table 28. Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 29. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Type (2024-2034)
Table 30. Global Hepatic Encephalopathy (HE) Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 31. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Application (2018-2023)
Table 32. Global Hepatic Encephalopathy (HE) Therapeutics Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 33. Global Hepatic Encephalopathy (HE) Therapeutics Revenue Market Share by Application (2024-2034)
Table 34. North America Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 35. North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 36. North America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 37. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 39. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 40. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Region (US$ Million): 2018 VS 2024 VS 2034
Table 41. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 42. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size by Region (2024-2034) & (US$ Million)
Table 43. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 44. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 45. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 46. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size Growth Rate by Country (US$ Million): 2018 VS 2024 VS 2034
Table 47. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 48. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size by Country (2024-2034) & (US$ Million)
Table 49. ASKA Pharmaceutical Company Detail
Table 50. ASKA Pharmaceutical Business Overview
Table 51. ASKA Pharmaceutical Hepatic Encephalopathy (HE) Therapeutics Product
Table 52. ASKA Pharmaceutical Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023) & (US$ Million)
Table 53. ASKA Pharmaceutical Recent Development
Table 54. COSMO PHARMACEUTICALS Company Detail
Table 55. COSMO PHARMACEUTICALS Business Overview
Table 56. COSMO PHARMACEUTICALS Hepatic Encephalopathy (HE) Therapeutics Product
Table 57. COSMO PHARMACEUTICALS Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023) & (US$ Million)
Table 58. COSMO PHARMACEUTICALS Recent Development
Table 59. Mallinckrodt Company Detail
Table 60. Mallinckrodt Business Overview
Table 61. Mallinckrodt Hepatic Encephalopathy (HE) Therapeutics Product
Table 62. Mallinckrodt Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023) & (US$ Million)
Table 63. Mallinckrodt Recent Development
Table 64. Valeant Company Detail
Table 65. Valeant Business Overview
Table 66. Valeant Hepatic Encephalopathy (HE) Therapeutics Product
Table 67. Valeant Revenue in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023) & (US$ Million)
Table 68. Valeant Recent Development
Table 69. Research Programs/Design for This Report
Table 70. Key Data Information from Secondary Sources
Table 71. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hepatic Encephalopathy (HE) Therapeutics Market Size Comparison by Type (2024-2034) & (US$ Million)
Figure 2. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Type: 2024 VS 2034
Figure 3. Lactulose Features
Figure 4. Rifaximin Features
Figure 5. Neomycin Features
Figure 6. Probiotics Features
Figure 7. Thiamine Features
Figure 8. Global Hepatic Encephalopathy (HE) Therapeutics Market Size Comparison by Application (2024-2034) & (US$ Million)
Figure 9. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Application: 2024 VS 2034
Figure 10. Acute Liver Failure Case Studies
Figure 11. Liver Cirrhosis Case Studies
Figure 12. Hepatic Encephalopathy (HE) Therapeutics Report Years Considered
Figure 13. Global Hepatic Encephalopathy (HE) Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 14. Global Hepatic Encephalopathy (HE) Therapeutics Market Size, (US$ Million), 2018 VS 2024 VS 2034
Figure 15. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Region: 2024 VS 2034
Figure 16. Global Hepatic Encephalopathy (HE) Therapeutics Market Share by Players in 2024
Figure 17. Global Top Hepatic Encephalopathy (HE) Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hepatic Encephalopathy (HE) Therapeutics as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Hepatic Encephalopathy (HE) Therapeutics Revenue in 2024
Figure 19. North America Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 20. North America Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2018-2034)
Figure 21. United States Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 22. Canada Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Europe Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2018-2034)
Figure 25. Germany Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 26. France Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 27. U.K. Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 28. Italy Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. Russia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. Nordic Countries Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Asia-Pacific Hepatic Encephalopathy (HE) Therapeutics Market Share by Region (2018-2034)
Figure 33. China Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. Japan Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 35. South Korea Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 36. Southeast Asia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 37. India Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 38. Australia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 39. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 40. Latin America Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2018-2034)
Figure 41. Mexico Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. Brazil Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Middle East & Africa Hepatic Encephalopathy (HE) Therapeutics Market Share by Country (2018-2034)
Figure 45. Turkey Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Saudi Arabia Hepatic Encephalopathy (HE) Therapeutics Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. ASKA Pharmaceutical Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
Figure 48. COSMO PHARMACEUTICALS Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
Figure 49. Mallinckrodt Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
Figure 50. Valeant Revenue Growth Rate in Hepatic Encephalopathy (HE) Therapeutics Business (2018-2023)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed